Anna Protopapas
Net worth: 948 250 $ as of 2026-05-30
Net worth: 948 250 $ as of 2026-05-30
Ms. Anna Protopapas is a Chief Executive Officer & Director at Flare Therapeutics, Inc. and an Independent Chairman at Nuvalent, Inc. She is on the Board of Directors at Flare Therapeutics, Inc. Ms. Protopapas was previously employed as an Independent Director by Dicerna Pharmaceuticals, Inc., an Independent Director by ARIAD Pharmaceuticals, Inc., an Executive VP-Global Business Development by Takeda Pharmaceutical Co., Ltd., a Head-Global Business Development by Takeda Pharmaceuticals International, Inc., and a President & Chief Executive Officer by Takeda Oncology Co. She also served on the board at Bioverativ, Inc., Mersana Therapeutics, Inc. and Ensemble Therapeutics Corp.
She received her undergraduate degree from Princeton University, a graduate degree from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-15 | 8,590 ( 0.01% ) | 948 250 $ | 2026-05-30 | |
| 2026-01-05 | 0 ( -.--% ) | - $ | 2025-12-30 |
| Companies | Position | Start |
|---|---|---|
| NUVALENT, INC. | Chairman | 2022-03-29 |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Chief Executive Officer | 2026-06-29 |
| Companies | Position | End |
|---|---|---|
| MERSANA THERAPEUTICS | Chief Executive Officer | 2023-09-09 |
| DICERNA PHARMACEUTICALS, INC. | Director/Board Member | 2021-06-02 |
| BIOVERATIV INC | Director/Board Member | 2018-03-07 |
| ARIAD PHARMACEUTICALS, INC. | Director/Board Member | 2017-01-15 |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Corporate Officer/Principal | 2014-09-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Ensemble Therapeutics Corp.
Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Develops novel classes of therapeutics and bioassays for research and diagnostics | Process Industries |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions